U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H25NO3.ClH
Molecular Weight 315.836
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AXOMADOL HYDROCHLORIDE

SMILES

Cl.COC1=CC=CC(=C1)[C@]2(O)C[C@@H](O)CC[C@H]2CN(C)C

InChI

InChIKey=BCTAUJYAQUAGMU-ZPQOTBKHSA-N
InChI=1S/C16H25NO3.ClH/c1-17(2)11-13-7-8-14(18)10-16(13,19)12-5-4-6-15(9-12)20-3;/h4-6,9,13-14,18-19H,7-8,10-11H2,1-3H3;1H/t13-,14-,16+;/m0./s1

HIDE SMILES / InChI

Molecular Formula C16H25NO3
Molecular Weight 279.3746
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Axomadol is a centrally active analgesic agent with opioid agonistic properties and with inhibitory effects on the reuptake of the monoamines noradrenaline and, to serotonin [5‐hydroxytrypyamine (5‐HT)]. The drug participated in phase II clinical trials in the treatment of patients with moderate to severe chronic low back pain. As a result, the axomadol didn’t meet predetermined study endpoint, and studies were discontinued.

Approval Year

Sample Use Guides

Axomadol was orally administered at doses ranging from 100 mg/day to 300 mg/day over a four-week period with a 12-week maintenance phase
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 12:44:20 GMT 2023
Edited
by admin
on Sat Dec 16 12:44:20 GMT 2023
Record UNII
B77S5W28H9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AXOMADOL HYDROCHLORIDE
Common Name English
GRT151
Code English
BN110
Code English
BN-110
Code English
GRT-151
Code English
Code System Code Type Description
WIKIPEDIA
Axomadol
Created by admin on Sat Dec 16 12:44:20 GMT 2023 , Edited by admin on Sat Dec 16 12:44:20 GMT 2023
PRIMARY
CAS
187219-95-0
Created by admin on Sat Dec 16 12:44:20 GMT 2023 , Edited by admin on Sat Dec 16 12:44:20 GMT 2023
PRIMARY
FDA UNII
B77S5W28H9
Created by admin on Sat Dec 16 12:44:20 GMT 2023 , Edited by admin on Sat Dec 16 12:44:20 GMT 2023
PRIMARY
PUBCHEM
70220033
Created by admin on Sat Dec 16 12:44:20 GMT 2023 , Edited by admin on Sat Dec 16 12:44:20 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY